PHARMO Institute Seroquel Safety Study - PHARMO II

Study identifier:D1443L00085

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Seroquel Safety Study

Medical condition

schizophrenia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

18325

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Sept 2010
Primary Completion Date: 01 Nov 2010
Study Completion Date: 01 Nov 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2014 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

PHARMO Institute for Drug Outcomes Research

Inclusion and exclusion criteria